Is a complete LON/HLN research report available?

No complete published report is available for lon/HLN (LON/HLN) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

lon/HLN stock profile: metrics, valuation and analysis

Market cap	29.4B
Revenue (ttm)	11.2B
Net income (ttm)	1.6B
EPS (ttm)	GBX 0.18
Shares out	8.8B
P/E (trailing)	18.4x
P/E (forward)	15.2x
Dividend	GBX 0.07 (2.04%)
Volume	23,434,631
Beta	0.25

All LON/HLN indicators

Market & fundamental data

Available fields

236

Groups with data

Currency

GBP

Showing 236 of 236 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United Kingdom
Country code	UK
Employees	24,535
Employees Change	-26%
Employees Change Percent	-0.11
Enterprise value	GBX 36.9B
Exchange	London Stock Exchange
Financial currency	GBP
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Industry PE	18.62
Industry PE Fwd	15.09
Isin	GB00BMX86B70
Last refreshed	2026-09-12
Market cap	GBX 29.4B
Price	GBX 334
Price currency	GBX
Rev Per Employee	454,534.34x
Sector	Healthcare
Sector PE	20.64
Sector PE Fwd	13.38
Sic	2834
Symbol	lon/HLN
Website	https://www.haleon.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	5.52%
EV Earnings	22.73x
EV/EBIT	14.09x
EV/EBITDA	12.71x
EV/FCF	15.94x
EV/Sales	3.31x
FCF yield	7.87%
Forward P/E	15.22x
P/B ratio	1.79x
P/E ratio	18.43x
P/S ratio	2.64x
PE Ratio3 Y	24.03x
PE Ratio5 Y	24.16x
PEG ratio	1.86x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	23.48%
EBITDA Margin	25.54%
FCF margin	20.76%
Gross margin	65.57%
Gross Profit	GBX 7.3B
Gross Profit Growth	4.4%
Gross Profit Growth Q	4.75%
Gross Profit Growth3 Y	1.16%
Gross Profit Growth5 Y	6.93%
Net Income	GBX 1.6B
Net Income Growth	6.64%
Net Income Growth Q	-5.46%
Net Income Growth Qo Q	-11.5%
Net Income Growth Years	2%
Net Income Growth3 Y	9.68%
Net Income Growth5 Y	19.9%
Pretax Margin	19.13%
Profit Margin	14.55%
Profit Per Employee	GBX 66,150
Profitable Quarters	GBX 10
Profitable Years	7
ROA	5.08
Roa5y	4.32
ROCE	9.94
ROE	10.09
Roe5y	7.32
ROIC	8.42
Roic5y	7.01

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-6.7%
Cagr3y	3.47%
Div CAGR3	20.23%
EPS Growth	8.46
EPS Growth Q	-4.49
EPS Growth Qo Q	-11.49
EPS Growth Years	2
EPS Growth3 Y	10.83
FCF Growth	4%
FCF Growth Q	0.32%
FCF Growth Qo Q	-32.37%
FCF Growth3 Y	9.07%
FCF Growth5 Y	31.18%
OCF Growth	6.64%
OCF Growth Q	1.66%
OCF Growth Qo Q	-35.03%
OCF Growth3 Y	7.53%
OCF Growth5 Y	27.53%
Revenue Growth	1.21x
Revenue Growth Q	2.23x
Revenue Growth Qo Q	0.94x
Revenue Growth Quarters	4x
Revenue Growth Years	0x
Revenue Growth3 Y	-0.75x
Revenue Growth5 Y	5.63x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	GBX 0.35
Assets	GBX 32.6B
Cash	GBX 826M
Current Assets	GBX 4.3B
Current Liabilities	GBX 6.2B
Debt	GBX 8.3B
Debt EBITDA	GBX 2.84
Debt Equity	GBX 0.5
Debt FCF	GBX 3.56
Equity	GBX 16.4B
Interest Coverage	8.08
Liabilities	GBX 16.1B
Long Term Assets	GBX 28.3B
Long Term Liabilities	GBX 9.9B
Net Cash	GBX -7.4B
Net Cash By Market Cap	GBX -25.25
Net Debt EBITDA	GBX 2.61
Net Debt Equity	GBX 0.45
Net Debt FCF	GBX 3.21
Tangible Book Value	GBX -9.4B
Tangible Book Value Per Share	GBX -1.05
WACC	5.03

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.69
Inventory Turnover	3.49
Net Working Capital	GBX -817M
Quick ratio	0.51
Working Capital	GBX -2B
Working Capital Turnover	GBX -8.67

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	1.66%
Dividend Growth	7.35%
Dividend Growth Years	2%
Dividend per share	GBX 0.07
Dividend Years	4
Dividend Yield	2.04%
Ex Div Date	2026-08-13
Last Dividend	GBX 0.02
Payout Frequency	Semi-Annual
Payout Ratio	39%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-6.69%
200-day SMA	363.2
3Y total return	10.77%
50-day SMA	361.9
50-day SMA vs 200-day SMA	50under200
All Time High	419.5
All Time High Change	-20.43%
All Time High Date	2025-05-30
All Time Low	241.2
All Time Low Change	38.39%
All Time Low Date	2022-09-05
ATR	7.4
Beta	0.25
Beta1y	0.21
Beta2y	0.23
Ch YTD	-10.94
High	337.6
High52	416.1
High52 Date	2026-02-18
High52ch	-19.78%
Low	333.4
Low52	274.4
Low52 Date	2025-09-22
Low52ch	21.65%
Ma50ch	-7.76%
Price vs 200-day SMA	-8.08%
RSI	29.42
RSI Monthly	44.96
RSI Weekly	39.35
Sharpe ratio	-0.33x
Sharpe Ratio3y	0.02x
Sortino ratio	-0.22
Sortino Ratio3y	0.3
Total Return	3.7%
Tr YTD	-9.13
Tr1m	-7.98%
Tr1w	-5.39%
Tr3m	-0.61%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	8,778,925,503%
Net Borrowing	-470,000,000
Shares Insiders	0.07%
Shares Institutions	94.12%
Shares Out	8,808,899,708
Shares Qo Q	-0.76%
Shares Yo Y	-1.66%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	GBX 2.2B
Adjusted OCF	2,554,000,000
Average Volume	21,908,994.8x
Bv Per Share	1.84
CAPEX	GBX -336M
Ch1m	-8.6
Ch1w	-5.39
Ch1y	-8.55
Ch3m	-1.27
Ch3y	4.67
Ch6m	-10.51
Change	-0.71%
Change From Open	-0.83
Close	336.2
Days Gap	0.12
Depreciation Amortization	230,000,000
Dollar Volume	7,822,479,827.8
Earnings Date	2026-10-30
EBIT	GBX 2.6B
EBITDA	GBX 2.8B
EPS	GBX 0.18
F Score	7
FCF	GBX 2.3B
FCF EV Yield	6.28x
FCF Per Share	GBX 0.26
Financing CF	-2,135,000,000
Fiscal Year End	December
Founded	1,715
Graham Number	278.15
Graham Upside	-16.67
Income Tax	GBX 496M
Investing CF	-332,000,000
Is Primary Listing	1
Last Earnings Date	2026-07-30
Last Report Date	2026-06-30
Lynch Fair Value	GBX 367
Lynch Upside	9.84
Ma150	360.5
Ma150ch	-7.4%
Ma20	356.2
Ma20ch	-6.29%
Net CF	179,000,000
Next Earnings Date	2026-10-30
Open	336.6
P FCF Ratio	12.7
P FCF Ratio SBC	13.26
P OCF Ratio	11.09
P OCF Ratio SBC	11.51
Payment Date	2026-09-17
Position In Range	9.52
Ppne	2,059,000,000
Price Date	2026-09-11
Price EBITDA	GBX 10.32
Relative Volume	1.1x
Revenue	11,152,000,000x
SBC By Revenue	0.87x
Share Based Comp	97,000,000
Tax By Revenue	4.45x
Tax Rate	23.25%
Tr6m	-8.7%
Volume	23,434,631
Z Score	2.92

LON/HLN (LON/HLN)

Price

Financial snapshot

Fair-value bridge

Latest news · LON/HLN

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All LON/HLN indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on LON/HLN

Frequently asked questions